“The CIIE is a unique platform and the best channel to cover the public in China and the entire Asia-Pacific region. This year’s Coronavirus (COVID-19) epidemic is of great significance.” For the upcoming 3rd China International Import Expo Wei Sitao, global CEO of Varian Medical, gave such a high evaluation.
Wei Sitao, global CEO of Varian Medical, said that the CIIE demonstrates that China has recovered so quickly from the epidemic and also declared China's confidence and commitment to openness to the outside world. At the same time, this is also a great encouragement to other countries in the world. Like a glare at the end of the tunnel, it sends a strong signal: We will definitely be able to overcome the epidemic. Varian Medical was founded in 1948 and entered China in 1983. It was the first high-tech company to settle in California's Silicon Valley, focusing on cancer treatment technologies and solutions, including radiotherapy, proton therapy and tumor intervention.
This year is the third time that Varian Medical has participated in the CIIE. Hay Think has learned that at this CIIE, Varian Medical will showcase the latest products and technologies for smart cancer treatment, including the smallest volume debut in Asia Pacific. Proton therapy system ProBeam 360, the world's first online adaptive radiotherapy platform Ethos driven by artificial intelligence, the latest generation of TrueBeam platform with real-time tracking and motion management functions, the smallest drug-loaded embolic microsphere for interventional tumor therapy, and the world's first A smart radiotherapy cloud ecological solution.
Wei Sitao said that he is full of expectations for this year's CIIE. This is the first time that Varian Medical has demonstrated a multidisciplinary comprehensive cancer treatment solution in an event. The goal of Varian Medical is to actively improve the treatment of cancer patients, and the CIIE is a powerful catalyst to promote the development of Varian and its industry, and benefit more patients.
It is worth mentioning that the cooperation projects reached by Varian Medical at this forward expo have gradually landed. For example, more than 40 memorandums of understanding were signed during the CIIE last year, and now more than 50% have been converted into contracts, including technology or Service category; HyperArc (Super Arc Knife) technology made its debut in China last year, and subsequently obtained marketing approval from the National Medical Products Administration that month, and will soon be put into clinical application in Peking Union Medical College Hospital; the TrueBeam radiotherapy equipment demonstrated last year has been in Shanghai Ruijin Hospital During installation and commissioning, the accessibility of radiosurgery will be further improved.
"We are full of confidence in the future of the Chinese market. No place can surpass China, so that we can achieve greater victory in the fight against cancer." Talking about the significance of the CIIE to Varian Medical, Wei Sitao said that the CIIE will help We have facilitated many fruitful exchanges, including with many colleagues in the medical industry and cancer treatment, important regulatory agencies and decision makers, and the general public.
According to China's cancer registration data in the past decade, the incidence and mortality of malignant tumors in China are still on the rise, and cancer prevention and treatment are facing huge challenges. From a corporate perspective, Wei Sitao believes that the huge challenge facing tumor diagnosis and treatment in the future is that the gap in demand for skilled clinical medical staff will continue to expand. By 2035, globally, we will need 150,000 new technicians, doctors and medical physicists to provide the medical services needed by patients.
How to deal with this challenge? Varian Medical believes that by connecting people, technology and data, a fully integrated and smarter way to fight cancer can be developed.
Wei Sitao introduced that Varian Medical is using its knowledge and expertise in this field to reduce the cost of technology popularization, and cross the field of radiotherapy technology. At the same time, Varian Medical is undergoing a transformation to find new ways to fight cancer, including improving the accessibility of cancer treatment, increasing the promotion of interdisciplinary treatment, and strengthening collaboration among all parties.
During the CIIE last year, Varian Medical’s smart cloud solution helped the medical consortium establish seamless collaboration between the upper and lower hospitals. At present, patients in the old area of Yimeng can receive high-quality radiotherapy at Yinan County People’s Hospital. After the radiotherapy experts of the county hospital push patient information to the cloud platform, the expert team of Shandong Cancer Hospital can now remotely access the county hospital with “one-click” The radiation treatment plan of the company is guided and optimized on the cloud, so that patients who are seriously ill can receive the same high-quality treatment as a tertiary hospital at the primary hospital at their doorstep.
Wei Sitao also said that the shortage of Chinese oncology professionals is more urgent, and China is advancing "new infrastructure", which will be a new powerful engine to promote the development of smart cancer treatment.